Misplaced Pages

Krebs–Henseleit solution

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Krebs-Henseleit solution)

Krebs–Henseleit solution, developed by Hans Krebs and Kurt Henseleit, is a solution containing sodium (Na), potassium (K), chloride (Cl), calcium (Ca), magnesium sulfate (MgSO4), bicarbonate (HCO3), phosphate (PO4), glucose, and sometimes supplemented with albumin, and tromethamine (THAM).

It has been used experimentally, for instance to study arteries ex vivo, in Langendorff heart preparations, and during isolated muscle testing of mammalian skeletal muscles.

References

  1. "Krebs-Henseleit (KH) Buffer". Cold Spring Harbor Protocols. 2006: pdb.rec581. 1 June 2006. doi:10.1101/pdb.rec581. Retrieved 6 May 2021.
  2. curehunter.com > Krebs–Henseleit solution Retrieved on April 14, 2010
  3. Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure". J. Soc. Gynecol. Investig. 10 (8): 490–5. doi:10.1016/S1071-5576(03)00149-7. PMID 14662162.
  4. Bailey, Leslie E.; Ong, Seok D. (August 1978). "Krebs-Henseleit solution as a physiological buffer in perfused and superfused preparations". Journal of Pharmacological Methods. 1 (2): 171–175. doi:10.1016/0160-5402(78)90022-0. Retrieved 6 May 2021.


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: